1. Home
  2. OGN

OGN

Organon & Co.

Logo Organon & Co.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Founded: 1923 Country:
United States
United States
Employees: N/A City: JERSEY CITY
Market Cap: 4.6B IPO Year: N/A
Target Price: $22.50 AVG Volume (30 days): 2.4M
Analyst Decision: Buy Number of Analysts: 4
Dividend Yield: 6.29% Dividend Payout Frequency: Quarterly
EPS: 3.99 EPS Growth: 11.14
52 Week Low/High: $10.84 - $24.79 Next Earning Date: 05-02-2024
Revenue: $6,263,000,000 Revenue Growth: 1.44%
Revenue Growth (this year): 3.23% Revenue Growth (next year): 1.84%

Share on Social Networks: